ORCID
- Sheridan, David: 0000-0001-5100-814X
DOI
10.1016/j.jhep.2022.02.033
Publication Date
2022-03-30
Publication Title
Journal of Hepatology
ISSN
0168-8278
Embargo Period
2022-04-23
Organisational Unit
Peninsula Medical School
Recommended Citation
Bowlus, C. L., Galambos, M., Aspinall, R., Hirschfield, G., Jones, D., Dörffel, Y., Gordon, S., Harrison, S., Kremer, A., Mayo, M., Thuluvath, P., Levy, C., Swain, M., Neff, G., Sheridan, D., Stanca, C., Berg, C., Goel, A., Shiffman, M., Vierling, J., Boudes, P., Steinberg, A., Choi, Y., & McWherter, C. (2022) 'A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis', Journal of Hepatology, . Available at: https://doi.org/10.1016/j.jhep.2022.02.033
